Neuland Laboratories Profit & Loss Annual

Trade
BSE: 524558 | NSE: NEULANDLAB | ISIN: INE794A01010 | Sector: Major Drugs
14,872.95 -31.30 (-0.21%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 1,558.581,191.20951.08936.91
Total Revenue 1,558.581,191.20951.08936.91
Costof Revenue Total 733.80605.62527.26531.99
Gross Profit 824.78585.58423.81404.93
Selling/ General/ Admin Expenses Total 257.06277.38253.11117.87
Depreciation/ Amortization 59.7052.4648.7839.68
Other Operating Expenses Total 105.135.355.634.90
Total Operating Expense 1,155.69960.93855.59827.34
Operating Income 402.89230.2795.49109.58
Interest Inc( Exp) Net- Non- Op Total -139.97-170.63-78.40-123.20
Other Net 12.543.41-3.688.35
Net Income Before Taxes 401.44215.7582.16105.33
Provisionfor Income Taxes 101.3652.2318.3424.70
Net Income After Taxes 300.08163.5263.8280.63
Net Income Before Extra Items 300.08163.5263.8280.63
Net Income 300.08163.5263.8280.63
Income Availableto Com Excl Extra Ord 300.08163.5263.8280.63
Income Availableto Com Incl Extra Ord 300.08163.5263.8280.63
Diluted Net Income 300.08163.5263.8280.63
Diluted Weighted Average Shares 1.281.281.281.28
Diluted EPS Excluding Extra Ord Items 233.89127.4549.7462.85
DPS- Common Stock Primary Issue 14.0010.005.005.00
Diluted Normalized EPS 233.89127.9650.8463.01
Research Development -198.08205.431,328.95
Interest Exp( Inc) Net- Operating Total -3.152.62-
Gain( Loss)on Saleof Assets --8.71-18.08-2.73
Total Extraordinary Items ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts